4.0 Article

Interleukin-6 inhibition as a potential therapeutic target in rheumatic diseases

Related references

Note: Only part of the references are listed.
Review Immunology

Immunotherapeutic implication of IL-6 blockade

Toshio Tanaka et al.

IMMUNOTHERAPY (2012)

Letter Rheumatology

Anti-interleukin 6 receptor therapy as rescue treatment for giant cell arteritis

Christian Beyer et al.

ANNALS OF THE RHEUMATIC DISEASES (2011)

Letter Rheumatology

Therapeutic effect of tocilizumab on two patients with polymyositis

Masashi Narazaki et al.

RHEUMATOLOGY (2011)

Editorial Material Rheumatology

Mixed response to tocilizumab for ankylosing spondylitis

Joerg C. Henes et al.

ANNALS OF THE RHEUMATIC DISEASES (2010)

Letter Rheumatology

Tocilizumab Ameliorates Clinical Symptoms in Polymyalgia Rheumatica

Keisuke Hagihara et al.

JOURNAL OF RHEUMATOLOGY (2010)

Editorial Material Rheumatology

Rapid improvement of AA amyloidosis with humanised anti-interleukin 6 receptor antibody treatment

S. Nishida et al.

ANNALS OF THE RHEUMATIC DISEASES (2009)

Article Rheumatology

Successful Treatment of Reactive Arthritis With a Humanized Anti-Interleukin-6 Receptor Antibody, Tocilizumab

Toshio Tanaka et al.

ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2009)